U.S. pharma huge copyright scrapped two experimental weight loss drugs past year—a at the time-every day capsule, lotiglipron, because of elevated liver enzymes in addition to a 2 times-everyday capsule, danuglipron, resulting from powerful Unwanted side effects—but CEO Albert Bourla has stated the company is decided to “Perform and acquire�